...
首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma
【24h】

Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma

机译:对肺鳞状细胞癌形成竞争内源性RNA网络的全基因组分析,MIRNA和MRNA

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose As a type of cancer with the highest morbidity and mortality, lung squamous cell carcinoma (LUSC) has a very poor prognosis. Long-non-coding RNA (lncRNA) has recently attracted attentions because it can play the role of competing endogenous RNA (ceRNA) to inhibit microRNA (miRNA) functions. In this study, we aimed to find prognosis-related lncRNAs, miRNAs and mRNAs and construct a prognosis-related ceRNA network. Methods The original LUSC RNA-sequencing data and miRNA profiles data were downloaded from the cancer genome atlas (TCGA) database. Differentially expressed lncRNAs, miRNAs and mRNAs were then identified between patients with lymph node metastasis and no lymph node metastasis. Univariate Cox regression analysis was performed to find the survival-associated lncRNAs, miRNAs and mRNAs. Subsequently, prognostic-related ceRNA network was established. By multivariate Cox regression analysis, three lncRNA signatures and three mRNA signatures were developed and used for predicting LUSC patients' survival. Results A total of 224 lncRNAs, 160 miRNAs, 913 mRNAs were identified between samples with lymph node metastasis and no lymph node metastasis. Univariate Cox regression analysis showed that, among them, 28 lncRNAs, 8 miRNAs, 105 mRNAs were significantly associated with patients' overall survival time. Further pathway and enrichment analysis suggested that these mRNAs were associated with the regulation of transmembrane transport, regulation of blood circulation, plasma lipoprotein particle organization. Then we constructed a survival-related ceRNA network including 9 lncRNAs, 8 miRNAs and 23 mRNAs. Additionally, a multivariate Cox regression analysis demonstrated that three lncRNAs (AL161431.1, LINC02389, APCDD1L.DT) and three mRNAs (KLK6, SLITRK5, CCDC177) had a significant prognostic value. Risk score indicated that lncRNA signature and mRNA signature could independently predict overall survival in LUSC patients. Conclusion The current study provided a better understanding of the ceRNA network in the progression of LUSC and laid a theoretical foundation for LUSC prognosis.
机译:目的作为一种具有最高发病率和死亡率的癌症,肺鳞状细胞癌(LUSC)预后非常差。长期非编码RNA(LNCRNA)最近吸引了关注,因为它可以发挥竞争内源性RNA(Cerna)来抑制MicroRNA(miRNA)功能的作用。在这项研究中,我们旨在寻找与预后相关的LNCRNA,MiRNA和MRNA,并构建与预后相关的Cerna网络。方法从癌症基因组Atlas(TCGA)数据库下载原始LUSC RNA测序数据和miRNA配置文件。然后在淋巴结转移患者和无淋巴结转移的患者之间鉴定差异表达的LNCRNA,miRNA和MRNA。进行单变量的Cox回归分析,以找到生存相关的LNCRNA,miRNA和MRNA。随后,建立了预后相关的Cerna网络。通过多变量COX回归分析,开发了三种LNCRNA签名和三个mRNA签名并用于预测LUSC患者的生存。结果总共224例,160 miRNA,913mRNA在具有淋巴结转移和无淋巴结转移的样品之间鉴定出样品。单变量Cox回归分析表明,其中,28例LNCRNA,8 miRNA,105 mRNA与患者的总生存时间显着相关。进一步的途径和富集分析表明,这些MRNA与跨膜运输的调节有关,血液循环调节,血浆脂蛋白颗粒组织。然后我们构建了一个与生存相关的Cerna网络,包括9个LNCRNA,8 MiRNA和23 MRNA。另外,多变量COX回归分析证明了三种LNCRNA(Al161431.1,LINC02389,APCDD1L.DT)和三个MRNA(KLK6,SLITRK5,CCDC177)具有显着的预后价值。风险评分表明,LNCRNA签名和mRNA签名可以独立预测LUSC患者的整体存活。结论目前的研究提供了对LUSC进展中的Cerna网络更好地了解,并为LUSC预后奠定了理论基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号